Literature DB >> 31502935

Preoperative CT Classification of the Resectability of Pancreatic Cancer: Interobserver Agreement.

Ijin Joo1, Jeong Min Lee1, Eun Sun Lee1, Jee-Young Son1, Dong Ho Lee1, Su Joa Ahn1, Won Chang1, Sang Min Lee1, Hyo-Jin Kang1, Hyun Kyung Yang1.   

Abstract

Background Accurate assessment of local resectability of pancreatic cancer at initial workup is critical to determine the most appropriate management strategy among up-front operation, neoadjuvant treatment, or palliative treatment. Purpose To investigate the interobserver agreement of the preoperative CT classification of the local resectability of pancreatic cancer and to determine if radiologist experience level impacts evaluation, and to evaluate the reader performance in assessing resectability at CT in a subset of patients with a reference standard for local resectability. Materials and Methods This retrospective study was composed of patients with pathologic-analysis-confirmed pancreatic cancers between January 2013 and December 2014 who underwent baseline multiphasic contrast agent-enhanced CT. Eight board-certified radiologists with different levels of experience (more experienced, ≥6 years, n = 4; less experienced, 1st- or 2nd-year fellows, n = 4) reviewed the CT images and classified cancers as resectable, borderline resectable, or unresectable. Interobserver agreements were determined for all reviewers and subgroups of reviewers stratified according to experience (more vs less) by using Fleiss κ statistics. In patients with reference standards for local resectability, diagnostic performances of each reviewer were assessed by using receiver operating characteristic curve analysis. Results There were 110 patients (mean age, 61 years ± 11; 60 men) who were evaluated. Overall interobserver agreements were moderate for resectability classification (κ = 0.48; 95% confidence interval: 0.45, 0.50). Only 30.0% of patients (33 of 110) were given the same resectability classification from all reviewers. More experienced reviewers demonstrated higher agreement in category assignments than less experienced reviewers (κ = 0.55 [95% confidence interval: 0.50, 0.60] vs 0.43 [95% confidence interval: 0.38, 0.49], respectively). For prediction at CT of margin-negative (ie, R0) resections (n = 82), areas under the receiver operating characteristic curve of all reviewers were greater than 0.80 (range, 0.83-0.96). However, borderline resectable cancers showed diverse R0 rates ranging from 0% to 74% depending on the reviewers. Conclusion Considerable interobserver variability exists in the assignment at CT of the local resectability of pancreatic cancer, even among experienced radiologists. © RSNA, 2019 Online supplemental material is available for this article.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31502935     DOI: 10.1148/radiol.2019190422

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  6 in total

Review 1.  The Role of Imaging in Current Treatment Strategies for Pancreatic Adenocarcinoma.

Authors:  Hyungjin Rhee; Mi Suk Park
Journal:  Korean J Radiol       Date:  2020-08-28       Impact factor: 3.500

2.  Radiomics-Assisted Presurgical Prediction for Surgical Portal Vein-Superior Mesenteric Vein Invasion in Pancreatic Ductal Adenocarcinoma.

Authors:  Fangming Chen; Yongping Zhou; Xiumin Qi; Rui Zhang; Xin Gao; Wei Xia; Lei Zhang
Journal:  Front Oncol       Date:  2020-11-16       Impact factor: 6.244

Review 3.  Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma: Role of the Radiologist and Oncologist in the Era of Precision Medicine.

Authors:  Federica Vernuccio; Carlo Messina; Valeria Merz; Roberto Cannella; Massimo Midiri
Journal:  Diagnostics (Basel)       Date:  2021-11-22

4.  Diagnostic Accuracy of CT for Evaluating Circumferential Resection Margin Status in Resectable or Borderline Resectable Pancreatic Head Cancer: A Prospective Study Using Axially Sliced Surgical Pathologic Correlation.

Authors:  Ji Hoon Park; Yoo-Seok Yoon; Seungjae Lee; Hae Young Kim; Ho-Seong Han; Jun Suh Lee; Won Chang; Haeryoung Kim; Hee Young Na; Seungyeob Han; Kyoung Ho Lee
Journal:  Korean J Radiol       Date:  2022-01-06       Impact factor: 3.500

Review 5.  [Radiologic Evaluation for Resectability of Pancreatic Adenocarcinoma].

Authors:  Shin Hye Hwang; Mi-Suk Park
Journal:  Taehan Yongsang Uihakhoe Chi       Date:  2021-03-31

6.  Systematic Analysis of Accuracy in Predicting Complete Oncological Resection in Pancreatic Cancer Patients-Proposal of a New Simplified Borderline Resectability Definition.

Authors:  Louisa Bolm; Katharina Mueller; Katharina May; Stefan Sondermann; Ekaterina Petrova; Hryhoriy Lapshyn; Kim Christin Honselmann; Dirk Bausch; Sergii Zemskov; Peter Bronsert; Tobias Keck; Steffen Deichmann; Ulrich F Wellner
Journal:  Cancers (Basel)       Date:  2020-04-04       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.